COMP <GO>
MELI vs PG // ALTMAN Z-SCORE & DEBT/EQUITY
MercadoLibre Inc. (NASDAQ) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: MELI 5
— PG 10
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: PG
LAST: $1,624.53 (-2.14%) • MKT CAP: $84.16B
balance-sheet
2.46
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
balance-sheet
5.59
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MELI VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MELI | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 63.20% | 51.20% | +12.00 | MELI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.90% | 25.40% | -11.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.0x | 16.2x | +7.80 | PG | /valuation <GO> |
| Free Cash Flow Yield | 13.31% | 3.77% | +9.54 | MELI | /fcf-yield <GO> |
| Operating Margin | 15.70% | 24.30% | -8.60 | PG | /operating-margins <GO> |
| Net Profit Margin | 9.80% | 19.00% | -9.20 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 34.30% | 0.30% | +34.00 | MELI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 2.46 | 5.59 | -3.13 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | MELI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.50% | +0.20 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.9 | 62.7 | -32.81 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.87 | +0.06 | MELI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.4x | 21.7x | +13.70 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $84.16B | $372.21B | -$288.05B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MELI REV | PG REV | MELI GROSS % | PG GROSS % | MELI FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.34B | $84.28B | 63.2% | 51.2% | $11.20B | $14.04B |
| FY 2024 | $15.14B | $84.04B | 63.3% | 51.4% | $7.24B | $16.52B |
| FY 2023 | $10.49B | $82.01B | 44.0% | 44.0% | $4.67B | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MELI // BETA 0.93
PG // BETA 0.87